Ascend Study - About the ASCEND Study

About the ASCEND Study

Thank you for your interest in the Ascend Study!

The ASCEND Study will be testing how a new investigational treatment, which is self-administered into the nose with a simple device, works to improve pain caused by migraine.

Migraine can be extremely debilitating and have a negative impact on one’s everyday life. There is a need to find a more effective way to treat the condition and give those who suffer from migraine a better quality of life as a result.

The study will last around 12 months. Participants who qualify and meet all other eligibility criteria will be trained in the use of the nasal device.

No one will receive a placebo in this study.

The ASCEND Study is evaluating a new investigational treatment option for migraine pain.